Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP434178.RAkzlPfxTmJ0iPiKhcswymUX8xaPf7A134KxUlqapROZE130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP434178.RAkzlPfxTmJ0iPiKhcswymUX8xaPf7A134KxUlqapROZE130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP434178.RAkzlPfxTmJ0iPiKhcswymUX8xaPf7A134KxUlqapROZE130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP434178.RAkzlPfxTmJ0iPiKhcswymUX8xaPf7A134KxUlqapROZE130_provenance.
- NP434178.RAkzlPfxTmJ0iPiKhcswymUX8xaPf7A134KxUlqapROZE130_assertion description "[These results suggest that PAK1 is essential for the malignant growth of NF2-deficient cells, and that PAK1-blocking drugs could be potentially useful forthe treatment of neurofibromatosis types 2, in addition to Ras-induced cancers and neurofibromatosis type 1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP434178.RAkzlPfxTmJ0iPiKhcswymUX8xaPf7A134KxUlqapROZE130_provenance.
- NP434178.RAkzlPfxTmJ0iPiKhcswymUX8xaPf7A134KxUlqapROZE130_assertion evidence source_evidence_literature NP434178.RAkzlPfxTmJ0iPiKhcswymUX8xaPf7A134KxUlqapROZE130_provenance.
- NP434178.RAkzlPfxTmJ0iPiKhcswymUX8xaPf7A134KxUlqapROZE130_assertion SIO_000772 15000491 NP434178.RAkzlPfxTmJ0iPiKhcswymUX8xaPf7A134KxUlqapROZE130_provenance.
- NP434178.RAkzlPfxTmJ0iPiKhcswymUX8xaPf7A134KxUlqapROZE130_assertion wasDerivedFrom befree-2016 NP434178.RAkzlPfxTmJ0iPiKhcswymUX8xaPf7A134KxUlqapROZE130_provenance.
- NP434178.RAkzlPfxTmJ0iPiKhcswymUX8xaPf7A134KxUlqapROZE130_assertion wasGeneratedBy ECO_0000203 NP434178.RAkzlPfxTmJ0iPiKhcswymUX8xaPf7A134KxUlqapROZE130_provenance.
- befree-2016 importedOn "2016-02-19" NP434178.RAkzlPfxTmJ0iPiKhcswymUX8xaPf7A134KxUlqapROZE130_provenance.